News

Patients with recurrence benefit from a combination of radiation and hormone therapy.

Gentle laser procedures for benign prostate enlargement place high demands on the surgeon's expertise.

Current physician ranking: Dr. Neubauer again voted among the best urologists in Germany.

Clinical trial tests the concept of "Active Surveillance" as an alternative therapy option.

PSMA, a new radioactive marker, detects tumor sites and metastases more accurately than choline PET/CT.

MRI: Is the biopsy unnecessary?

More safety in prostate cancer diagnostics: State-of-the-art MRI (3 Tesla)-supported biopsy at the West German Prostate Center in Cologne.

Current study of the Charité: Mortality risk in localized prostate cancer is greatly overestimated.

"The PSA test is useless and sometimes even dangerous." This statement is erroneously transported more and more often by the media.

While organ-preserving therapies are now standard for breast or kidney tumors, this type of treatment is still in its infancy for prostate cancer.

The risk of developing bladder or rectal cancer as a secondary tumor after irradiation of the prostate using brachytherapy is lower than after complete removal of the prostate.

Far gentler than conventional excision (TURP) of the prostate are modern laser procedures such as greenlight laser therapy or the diode laser procedure.